Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;6(4):204-6.
doi: 10.1159/000440660. Epub 2015 Sep 18.

Mitochondrial Dysfunction in a Patient with 8q21.11 Deletion and Charcot-Marie-Tooth Disease Type 2K due to GDAP1 Haploinsufficiency

Affiliations

Mitochondrial Dysfunction in a Patient with 8q21.11 Deletion and Charcot-Marie-Tooth Disease Type 2K due to GDAP1 Haploinsufficiency

Dmitriy Niyazov et al. Mol Syndromol. 2015 Oct.

Abstract

Unbalanced chromosomal rearrangements typically cause multiple organ system involvement including neurodevelopmental deficits. It is atypical, however, to experience developmental and neurological regression. We describe a female with intellectual disability, failure to thrive, short stature, multiple congenital anomalies, and dysmorphic features and a previously diagnosed de novo 8q21.11 deletion at the age of 7. However, at the age of 11, she experienced neurological and developmental regression. The GDAP1 gene encoding ganglioside-induced differentiation-associated protein 1 was deleted in the patient as a part of the contiguous gene syndrome. We argue that haploinsufficiency of GDAP1 could have contributed to the proband's regression based on its involvement in mitochondrial function and a signal transduction pathway in neuronal development.

Keywords: 8q21.11 deletion; Charcot-Marie-Tooth disease type 2; GDAP1; Mitochondrial dysfunction.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The 11.8-Mb deletion detected by the 105K oligonucleotide aCGH in 8q21.118q21.2.
Fig. 2
Fig. 2
The proband before and 3 months after gastrostomy placement and mitochondrial vitamin cocktail.

References

    1. Bird TD. Charcot-Marie-Tooth neuropathy type 2. In: Pagon RA, Adam MP, Bird TD, editors. GeneReviews® [Internet] Seattle: University of Washington; 1998. http://www.ncbi.nlm.nih.gov/books/NBK1285.
    1. Cassereau J, Chevrollier A, Gueguen N, Desquiret V, Verny C, et al. Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations. Exp Neurol. 2011;227:31–41. - PubMed
    1. Chinnery PF. Mitochondrial disorders overview, in Pagon RA, Adam MP, Ardinger HH, et al (eds): GeneReviews® [Internet]. (University of Washington, Seattle 2000). http://www.ncbi.nlm.nih.gov/books/NBK1224. - PubMed
    1. Knott A, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci. 2008;9:505–518. - PMC - PubMed
    1. Palomares M, Delicado A, Mansilla E, de Torres ML, Vallespín E, et al. Characterization of a 8q21.11 microdeletion syndrome associated with intellectual disability and a recognizable phenotype. Am J Hum Genet. 2011;89:295–301. - PMC - PubMed